Tradestie Institutional Equity Comparison Engine

VOR vs IMCR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VOR Overall Edge

VOR Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vor Biopharma Inc. Common Stock (VOR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while IMCR counters with relative strength in Valuation. Fundamentally, VOR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IMCR at 23.8x Forward P/E and -2.2% operating margin (-1.4% YoY). In options structure, VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against IMCR sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IMCR
VOR N/M vs IMCR 23.8x Fwd P/E
Growth & Margin Winner VOR
Op Margin 0.0% vs -2.2% ยท YoY +0.0% vs -1.4%
Momentum & Technical Winner VOR
1Y +97.5% vs -17.8% ยท 52W Pos 65% vs 12%
Options & Structure Winner VOR
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (10th %ile IV)
VOR NASDAQ
Vor Biopharma Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$19.26
-0.82% 1D
Market Cap $1.2B
1M Return +6.82%
1Y Return +97.54%
Forward P/E N/M
Unified AI Score
57.8 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 66.0 Mom 50.0
IMCR NASDAQ
Immunocore Holdings plc American Depositary Shares
Biological Products, (No Disgnostic Substances)
$29.07
-2.89% 1D
Market Cap $1.6B
1M Return -1.11%
1Y Return -17.8%
Forward P/E 23.8x
Unified AI Score
46.3 / 100 HOLD
Tech 46.0 Fund 50.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VOR +97.54% IMCR -17.8% Spread: +115.34 pp (VOR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VOR TTM Op. Margin: 0.0% IMCR TTM Op. Margin: -2.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VOR vs IMCR. Trailing 12-month operating profitability (VOR 0.0% vs IMCR -2.2%) and valuation multiples (VOR N/M vs IMCR 23.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VOR (6) vs IMCR (4)
Institutional Metric VOR IMCR Criterion Row Winner
Market Capitalization Scale $1.2B $1.6B Larger Scale IMCR
Trailing P/E Ratio Valuation 0.1x 23.8x Lower Multiple VOR
Forward P/E Ratio Valuation N/M 23.8x Lower Multiple IMCR
Revenue Growth (YoY) Growth +0.0% -1.4% Higher Growth VOR
Operating Margin (TTM) Profitability 0.0% -2.2% Higher Margin VOR
Net Profit Margin Profitability 0.0% -7.5% Higher Margin VOR
Return on Equity (ROE) Capital Efficiency -125.4% -7.9% Higher ROE IMCR
52-Week Range Position Momentum 65% ($6โ€“$26) 12% ($28โ€“$41) Stronger Trend VOR
Beta / 30D Volatility Risk Regime 1.91ฮฒ ยท 61% Vol 0.63ฮฒ ยท 59% Vol Lower Realized Risk IMCR
Unified Institutional Score Composite Signal 57.8 / 100 (HOLD) 46.3 / 100 (HOLD) Higher Composite VOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VOR vs IMCR Buy Guide
VOR CONSOLIDATION
52d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live VOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IMCR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live IMCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VOR nor IMCR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.